Patients treated with intravenous t‐PA among three groups were the youngest, had the highest proportion of current smoking, atrial fibrillation, and pre‐mRS score of 0–1, had the lowest proportion of diabetes mellitus, taking antiplatelet and lipid‐lowering agents, and had the highest baseline NIHSS. The gene discussed is PLAT; the disease is atrial fibrillation.